𝔖 Bobbio Scriptorium
✦   LIBER   ✦

632 Discrepancy Between Virological Breakthrough and Confirmed Genotypic Resistance in Chronic Hepatitis B Patients Receiving Nucleos(T)Ide Analogue Therapy in Clinical Practice

✍ Scribed by Hongthanakorn, Chanunta; Chotiyaputta, Watcharasak; Oberhelman, Kelly; Fontana, Robert J.; Marrero, Jorge A.; Licari, Tracy L.; Lok, Anna S.

Book ID
122352032
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
106 KB
Volume
138
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Virological breakthrough and resistance
Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
✍ Ezequiel Ridruejo; RaΓΊl Adrover; Marcelo O. Silva πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 255 KB

We read with great interest the article by Teixera-Clerc et al., 1 regarding the hepatoprotective properties displayed by cannabinoid receptor 2 (CB2) agonists in a mouse model of carbon tetrachloride (CCl 4 )-induced liver injury. Acute hepatitis induced by CCl 4 was accelerated in CB2 knockout mic

Discrepancy of potential antiviral resis
Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China
✍ Xiao-Guang Li; Bao-Ming Liu; Jie Xu; Xue-En Liu; Hai Ding; Tong Li πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## Abstract Little is known about the discrepancy of the potential antiviral resistance mutation profiles within the hepatitis B virus (HBV) reverse transcriptase (RT) between nucleos(t)ide analogue (NA)‐untreated and ‐treated patients with chronic hepatitis B. Full‐length HBV RT sequences from 59